Dabur is India’s leading FMCG, Ayurvedic and natural health care company with wide network distribution across world.
The moat is built on a massive brand portfolio rooted in Ayurvedic heritage and a distribution network that is the second largest in India, reaching 8.5 million outlets. This is corroborated by a durable average ROCE of 25.8% and the ability to maintain high net margins (15.7%) despite significant raw material inflation.
Management prioritizes reinvestment in manufacturing capacity and brand building, supplemented by disciplined M&A such as the Badshah Masala acquisition and the launch of Dabur Ventures. They maintain a healthy dividend payout ratio of approximately 77% while keeping debt levels negligible.
Five years out, the investment collapsed because the company's growth engine stalled while its cost structure bloated. Stagnant EPS growth, already visible in the 3% CAGR, failed to keep pace with inflation as the Ayurvedic niche became commoditized by aggressive local players and the market leader in oral care. The heavy reliance on seasonal products backfired during a multi-year cycle of erratic weather, while the US hair relaxer litigation escalated from a minor red flag into a massive capital drain. Ultimately, the market stopped paying a premium for a low-growth business that proved unable to pass on rising raw material costs to a price-sensitive rural consumer base.
RichFakir rates Dabur India Ltd's business quality as decent — 75/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as wide.
On our model, Dabur India Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Dabur India Ltd is: Watch — wait for price. A decent business, but at an expensive price against our estimate of fair value — one to keep on the watchlist for a better entry. We marked it down a notch: revenue and earnings barely grow — a steady cash cow, not a compounder.
RichFakir's educational estimate of Dabur India Ltd's fair value is about ₹136 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →